(±)-Glycidol structure
|
Common Name | (±)-Glycidol | ||
|---|---|---|---|---|
| CAS Number | 60456-23-7 | Molecular Weight | 74.078 | |
| Density | 1.2±0.1 g/cm3 | Boiling Point | 162.4±8.0 °C at 760 mmHg | |
| Molecular Formula | C3H6O2 | Melting Point | N/A | |
| MSDS | Chinese USA | Flash Point | 81.1±0.0 °C | |
| Symbol |
GHS05, GHS06, GHS08 |
Signal Word | Danger | |
| Name | (S)-glycidol |
|---|---|
| Synonym | More Synonyms |
| Density | 1.2±0.1 g/cm3 |
|---|---|
| Boiling Point | 162.4±8.0 °C at 760 mmHg |
| Molecular Formula | C3H6O2 |
| Molecular Weight | 74.078 |
| Flash Point | 81.1±0.0 °C |
| Exact Mass | 74.036781 |
| PSA | 32.76000 |
| LogP | -0.95 |
| Vapour Pressure | 0.7±0.7 mmHg at 25°C |
| Index of Refraction | 1.455 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
MUTATION DATA
|
| Symbol |
GHS05, GHS06, GHS08 |
|---|---|
| Signal Word | Danger |
| Hazard Statements | H302-H312-H315-H318-H331-H335-H350-H360 |
| Precautionary Statements | P201-P261-P280-P305 + P351 + P338-P311 |
| Personal Protective Equipment | Eyeshields;Faceshields;full-face respirator (US);Gloves;multi-purpose combination respirator cartridge (US);type ABEK (EN14387) respirator filter |
| Hazard Codes | T:Toxic; |
| Risk Phrases | R45;R60;R21/22;R23;R36/37/38;R68 |
| Safety Phrases | S53-S45 |
| RIDADR | UN 2810 |
| WGK Germany | 3 |
| RTECS | RR0508100 |
| Hazard Class | 6.1 |
| HS Code | 2910900090 |
| Precursor 9 | |
|---|---|
| DownStream 10 | |
| HS Code | 2910900090 |
|---|---|
| Summary | 2910900090. epoxides, epoxyalcohols, epoxyphenols and epoxyethers, with a three-membered ring, and their halogenated, sulphonated, nitrated or nitrosated derivatives. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:5.5%. General tariff:30.0% |
|
Direct Determination of MCPD Fatty Acid Esters and Glycidyl Fatty Acid Esters in Vegetable Oils by LC-TOFMS.
J. Am. Oil Chem. Soc. 88(1) , 1-14, (2011) Analysis of MCPD esters and glycidyl esters in vegetable oils using the indirect method proposed by the DGF gave inconsistent results when salting out conditions were varied. Subsequent investigation ... |
|
|
Cross metathesis as a general strategy for the synthesis of prostacyclin and prostaglandin analogues.
Org. Lett. 8 , 3101, (2006) [reaction: see text] A cross metathesis (CM) approach has been successfully applied to introduce fully functionalized omega-side chain appendages of various prostacyclin and prostaglandin analogues, r... |
| (S)-(-)-2,3-epoxy-1-propanol |
| 2-Oxiranylmethanol |
| (2S)-2-Oxiranylmethanol |
| (S)-(-)-2-(Hydroxymethyl)oxirane |
| 2-Oxiranemethanol, (2S)- |
| (2S)-Oxiran-2-ylmethanol; (2S)-(-)-2,3-Epoxypropan-1-ol |
| (2S)-(-)-3-Hydroxy-1,2-propenoxide |
| MFCD00074874 |
| (2S)-Oxiran-2-ylmethanol |
| (S)-(-)-Glycidol |
| [(2S)-oxiran-2-yl]methanol |
| (S)-Glycidol |
| Glycidol |
| UNII:S54CF1DV9A |
| (R,S)-Glycidol |
| oxiran-2-ylmethanol |
| (S)-(-)-1-hydroxy-2,3-epoxypropane |
| 2-Oxiranemethanol |
| (±)-GLYCIDOL |